These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma]. Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855 [TBL] [Abstract][Full Text] [Related]
4. Tumor uptake of intravenously administered radiolabeled antibodies in ovarian carcinoma patients in relation to antigen expression and other tumor characteristics. Buist MR; Kenemans P; Molthoff CF; Roos JC; Den Hollander W; Brinkhuis M; Baak JP Int J Cancer; 1995 Apr; 64(2):92-8. PubMed ID: 7615359 [TBL] [Abstract][Full Text] [Related]
5. Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody. Krag DN; Ford P; Smith L; Taylor M; Schneider PD; Bushberg JT; Goodnight JE Arch Surg; 1993 Jul; 128(7):819-23. PubMed ID: 8317965 [TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer. Brökelmann J; Bockisch A; Vogel J; Reinsberg J; Oehr P; Biersack HJ; Krebs D Arch Gynecol Obstet; 1989; 244(4):193-206. PubMed ID: 2782949 [TBL] [Abstract][Full Text] [Related]
7. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies]. Peking A; Marinov V Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792 [TBL] [Abstract][Full Text] [Related]
8. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies]. Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446 [TBL] [Abstract][Full Text] [Related]
9. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125. Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36. Symonds EM; Perkins AC; Pimm MV; Baldwin RW; Hardy JG; Williams DA Br J Obstet Gynaecol; 1985 Mar; 92(3):270-6. PubMed ID: 3978057 [TBL] [Abstract][Full Text] [Related]
11. [Immunoscintigraphy of oncologic tumors]. Barzen G Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627 [TBL] [Abstract][Full Text] [Related]
12. [Immunoscintigraphy, an aid to the oncologist--the Rennes experience in using anti-CEA, anti-CA 19.9 monoclonal antibodies and radiolabelled OC-125]. Herry JY; Bourguet P; Kerbrat P; Le Prise E; Ben Hassel M; Gedouin D; Richier JL Allerg Immunol (Paris); 1987 May; 19(5):180-8. PubMed ID: 3330945 [TBL] [Abstract][Full Text] [Related]
13. OC125 immunoscintigraphy in ovarian carcinoma: a comparison with alternative methods of assessment. Maughan TS; Haylock B; Hayward M; Facey P; Evans WD; Shelley MD; Fish RG; Adams M Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):199-205. PubMed ID: 2261415 [TBL] [Abstract][Full Text] [Related]
14. Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125. Muto MG; Lepisto EM; Van den Abbeele AD; Knapp RC; Kassis AI Am J Obstet Gynecol; 1989 Nov; 161(5):1206-12. PubMed ID: 2686446 [TBL] [Abstract][Full Text] [Related]